Cross-talks of glycosylphosphatidylinositol biosynthesis with glycosphingolipid biosynthesis and ER-associated degradation.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
13 02 2020
Historique:
received: 25 08 2019
accepted: 27 01 2020
entrez: 15 2 2020
pubmed: 15 2 2020
medline: 28 4 2020
Statut: epublish

Résumé

Glycosylphosphatidylinositol (GPI)-anchored proteins and glycosphingolipids interact with each other in the mammalian plasma membranes, forming dynamic microdomains. How their interaction starts in the cells has been unclear. Here, based on a genome-wide CRISPR-Cas9 genetic screen for genes required for GPI side-chain modification by galactose in the Golgi apparatus, we report that β1,3-galactosyltransferase 4 (B3GALT4), the previously characterized GM1 ganglioside synthase, additionally functions in transferring galactose to the N-acetylgalactosamine side-chain of GPI. Furthermore, B3GALT4 requires lactosylceramide for the efficient GPI side-chain galactosylation. Thus, our work demonstrates previously unexpected functional relationships between GPI-anchored proteins and glycosphingolipids in the Golgi. Through the same screening, we also show that GPI biosynthesis in the endoplasmic reticulum (ER) is severely suppressed by ER-associated degradation to prevent GPI accumulation when the transfer of synthesized GPI to proteins is defective. Our data demonstrates cross-talks of GPI biosynthesis with glycosphingolipid biosynthesis and the ER quality control system.

Identifiants

pubmed: 32054864
doi: 10.1038/s41467-020-14678-2
pii: 10.1038/s41467-020-14678-2
pmc: PMC7018848
doi:

Substances chimiques

Glycosphingolipids 0
Glycosylphosphatidylinositols 0
Recombinant Fusion Proteins 0
Acyltransferases EC 2.3.-
COOH-terminal signal transamidase EC 2.3.2.-
Galactosyltransferases EC 2.4.1.-
UDP-Gal-betaGlcNAc beta 1,3-galactosyltransferase, human EC 2.4.1.62

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

860

Références

Ferguson, M. A. J., Hart, G. W. & Kinoshita, T. Glycosylphosphatidylinositol Anchors. (eds Varki A. et al.) (Cold Spring Harbor Laboratory Press, Cold Spring Harbor (NY), 2017).
Kinoshita, T. & Fujita, M. Biosynthesis of GPI-anchored proteins: special emphasis on GPI lipid remodeling. J. Lipid Res. 57, 6–24 (2016).
pubmed: 26563290 pmcid: 4689344 doi: 10.1194/jlr.R063313
Homans, S. W. et al. Complete structure of the glycosyl phosphatidylinositol membrane anchor of rat brain Thy-1 glycoprotein. Nature 333, 269–272 (1988).
pubmed: 2897081 doi: 10.1038/333269a0 pmcid: 2897081
Stahl, N. et al. Glycosylinositol phospholipid anchors of the scrapie and cellular prion proteins contain sialic acid. Biochemistry 31, 5043–5053 (1992).
pubmed: 1350920 doi: 10.1021/bi00136a600 pmcid: 1350920
Hirata, T. et al. Identification of a Golgi GPI-N-acetylgalactosamine transferase with tandem transmembrane regions in the catalytic domain. Nat. Commun. 9, 405 (2018).
pubmed: 29374258 pmcid: 5785973 doi: 10.1038/s41467-017-02799-0
Bate, C., Nolan, W. & Williams, A. Sialic acid on the glycosylphosphatidylinositol anchor regulates PrP-mediated cell signaling and prion formation. J. Biol. Chem. 291, 160–170 (2016).
pubmed: 26553874 doi: 10.1074/jbc.M115.672394
Puig, B. et al. GPI-anchor signal sequence influences PrP C sorting, shedding and signalling, and impacts on different pathomechanistic aspects of prion disease in mice. PLoS Pathog. 15, e1007520 (2019).
pubmed: 30608982 pmcid: 6334958 doi: 10.1371/journal.ppat.1007520
Katorcha, E., Srivastava, S., Klimova, N. & Baskakov, I. V. Sialylation of glycosylphosphatidylinositol (GPI) Anchors of mammalian prions is regulated in a Host-, Tissue-, and Cell-specific manner. J. Biol. Chem. 291, 17009–17019 (2016).
pubmed: 27317661 pmcid: 5016106 doi: 10.1074/jbc.M116.732040
Schnaar, R. L. & Kinoshita, T. in Essentials of Glycobiology [Internet]. 3rd edition (eds Varki A. et al.). Glycosphingolipids. (Cold Spring Harbor Laboratory Press, 2017).
Brown, D. A. & Rose, J. K. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68, 533–544 (1992).
pubmed: 1531449 doi: 10.1016/0092-8674(92)90189-J
Simons, K. & Ikonen, E. Functional rafts in cell membranes. Nature 387, 569–572 (1997).
pubmed: 9177342 doi: 10.1038/42408
Sezgin, E., Levental, I., Mayor, S. & Eggeling, C. The mystery of membrane organization: Composition, regulation and roles of lipid rafts. Nat. Rev. Mol. Cell Biol. 18, 361–374 (2017).
pubmed: 28356571 pmcid: 5500228 doi: 10.1038/nrm.2017.16
Raghupathy, R. et al. Transbilayer lipid interactions mediate nanoclustering of lipid-anchored proteins. Cell 161, 581–594 (2015).
pubmed: 25910209 pmcid: 4651428 doi: 10.1016/j.cell.2015.03.048
Gkantiragas, I. et al. Sphingomyelin-enriched Microdomains at the Golgi Complex. Mol. Biol. Cell 12, 1819–1833 (2001).
pubmed: 11408588 pmcid: 37344 doi: 10.1091/mbc.12.6.1819
van Galen, J. et al. Sphingomyelin homeostasis is required to form functional enzymatic domains at the trans-Golgi network. J. Cell Biol. 206, 609–618 (2014).
pubmed: 25179630 pmcid: 4151138 doi: 10.1083/jcb.201405009
Koikeda, M. et al. Raft-based interactions of gangliosides with a GPI-anchored receptor. Nat. Chem. Biol. 12, 402–410 (2016).
pubmed: 27043189 doi: 10.1038/nchembio.2059
Striepen, B. et al. Molecular structure of the ‘low molecular weight antigen’ of Toxoplasma gondii: a glucose α1-4 N-acetylgalactosamine makes free glycosyl-phosphatidylinositols highly immunogenic. J. Mol. Biol. 266, 797–813 (1997).
pubmed: 9102470 doi: 10.1006/jmbi.1996.0806
Wang, Y. et al. Free, unlinked glycosylphosphatidylinositols on mammalian cell surfaces revisited. J. Biol. Chem. 294, 5038–5049 (2019).
pubmed: 30728244 doi: 10.1074/jbc.RA119.007472
Nguyen, T. T. M. et al. Mutations in PIGS, encoding a GPI transamidase, cause a neurological syndrome ranging from fetal akinesia to epileptic encephalopathy. Am. J. Hum. Genet. 103, 602–611 (2018).
pubmed: 30269814 pmcid: 6174287 doi: 10.1016/j.ajhg.2018.08.014
Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783–784 (2014).
pubmed: 4486245 pmcid: 4486245 doi: 10.1038/nmeth.3047
Li, W. et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens. Genome Biol. 15, 554 (2014).
pubmed: 25476604 pmcid: 25476604 doi: 10.1186/s13059-014-0554-4
Potelle, S. et al. Glycosylation abnormalities in Gdt1p/TMEM165 deficient cells result from a defect in Golgi manganese homeostasis. Hum. Mol. Genet. 25, 1489–1500 (2016).
pubmed: 27008884 doi: 10.1093/hmg/ddw026 pmcid: 27008884
Tai, G. Participation of the syntaxin 5/Ykt6/GS28/GS15 SNARE complex in transport from the early/recycling endosome to the trans-Golgi network. Mol. Biol. Cell 15, 4011–4022 (2004).
pubmed: 15215310 pmcid: 515336 doi: 10.1091/mbc.e03-12-0876
Selyunin, A. S., Iles, L. R., Bartholomeusz, G. & Mukhopadhyay, S. Genome-wide siRNA screen identifies UNC50 as a regulator of Shiga toxin 2 trafficking. J. Cell Biol. 216, 3249–3262 (2017).
pubmed: 28883040 pmcid: 5626549 doi: 10.1083/jcb.201704015
Amado, M. et al. A family of human β3-galactosyltransferases: Characterization of four members of a UDP-galactose:β-N-acetyl-glucosamine/β-N-acetyl-galactosamine β−1,3-galactosyltransferase family. J. Biol. Chem. 273, 12770–12778 (1998).
pubmed: 9582303 doi: 10.1074/jbc.273.21.12770
Miyazaki, H. et al. Expression cloning of rat cDNA encoding UDP-galactose:G(D2) β1,3- galactosyltransferase that determines the expression of G(D1b)/G(M1)/G(A1). J. Biol. Chem. 272, 24794–24799 (1997).
pubmed: 9312075 doi: 10.1074/jbc.272.40.24794
Ichikawa, S., Sakiyama, H., Suzuki, G., Hidari, K. I. & Hirabayashi, Y. Expression cloning of a cDNA for human ceramide glucosyltransferase that catalyzes the first glycosylation step of glycosphingolipid synthesis. Proc. Natl Acad. Sci. USA 93, 4638–4643 (1996).
pubmed: 8643456 doi: 10.1073/pnas.93.10.4638
Kikkert, M. et al. Human HRD1 is an E3 Ubiquitin ligase involved in degradation of proteins from the endoplasmic reticulum. J. Biol. Chem. 279, 3525–3534 (2004).
pubmed: 14593114 doi: 10.1074/jbc.M307453200
Mueller, B., Klemm, E. J., Spooner, E., Claessen, J. H. & Ploegh, H. L. SEL1L nucleates a protein complex required for dislocation of misfolded glycoproteins. Proc. Natl Acad. Sci. USA 105, 12325–12330 (2008).
pubmed: 18711132 doi: 10.1073/pnas.0805371105
Fujita, M., Yoko-O, T. & Jigami, Y. Inositol deacylation by Bst1p is required for the quality control of glycosylphosphatidylinositol-anchored proteins. Mol. Biol. Cell 17, 834–850 (2006).
pubmed: 16319176 pmcid: 1356593 doi: 10.1091/mbc.e05-05-0443
Sikorska, N. et al. Limited ER quality control for GPI-anchored proteins. J. Cell Biol. 213, 693–704 (2016).
pubmed: 27325793 pmcid: 4915193 doi: 10.1083/jcb.201602010
Nakano, Y., Noda, K., Endo, T., Kobata, A. & Tomita, M. Structural study on the glycosyl-phosphatidylinositol anchor and the asparagine-linked sugar chain of a soluble form of CD59 in human urine. Arch. Biochem. Biophys. 311, 117–126 (1994).
pubmed: 7514386 doi: 10.1006/abbi.1994.1216
Yang, J. et al. The I-TASSER suite: protein structure and function prediction. Nat. Methods 12, 7–8 (2014).
doi: 10.1038/nmeth.3213
Pedersen, L. C. et al. Heparan/chondroitin sulfate biosynthesis. Structure and mechanism of human glucuronyltransferase I. J. Biol. Chem. 275, 34580–34585 (2000).
pubmed: 10946001 doi: 10.1074/jbc.M007399200
Jinek, M., Chen, Y. W., Clausen, H., Cohen, S. M. & Conti, E. Structural insights into the Notch-modifying glycosyltransferase Fringe. Nat. Struct. Mol. Biol. 13, 945–946 (2006).
pubmed: 16964258 doi: 10.1038/nsmb1144
Marks, D. L., Dominguez, M., Wu, K. & Pagano, R. E. Identification of active site residues in glucosylceramide synthase. J. Biol. Chem. 276, 26492–26498 (2001).
pubmed: 11337504 doi: 10.1074/jbc.M102612200
Nishie, T. et al. β4-Galactosyltransferase-5 is a lactosylceramide synthase essential for mouse extra-embryonic development. Glycobiology 20, 1311–1322 (2010).
pubmed: 20574042 doi: 10.1093/glycob/cwq098
Tokuda, N. et al. β4GalT6 is involved in the synthesis of lactosylceramide with less intensity than β4GalT5. Glycobiology 23, 1175–1183 (2013).
pubmed: 23882130 doi: 10.1093/glycob/cwt054
Gastinel, L. N., Cambillau, C. & Bourne, Y. Crystal structures of the bovine β4galactosyltransferase catalytic domain and its complex with uridine diphosphogalactose. EMBO J. 18, 3546–3557 (1999).
pubmed: 10393171 pmcid: 1171433 doi: 10.1093/emboj/18.13.3546
Fukumoto, S. et al. Expression cloning of mouse cDNA of CMP-NeuAc:lactosylceramide α2,3- sialyltransferase, an enzyme that initiates the synthesis of gangliosides. J. Biol. Chem. 274, 9271–9276 (1999).
pubmed: 10092602 doi: 10.1074/jbc.274.14.9271
Nagata, Y. et al. Expression cloning of beta 1,4 N-acetylgalactosaminyltransferase cDNAs that determine the expression of GM2 and GD2 gangliosides [published erratum appears in J Biol Chem 1994 Mar 4;269(9):7045]. J. Biol. Chem. 267, 12082–12089 (1992).
pubmed: 1601877
Yoshihara, T. et al. Lactosylceramide synthases encoded by B4galt5 and 6 genes are pivotal for neuronal generation and myelin formation in mice. PLoS Genet. 14, e1007545 (2018).
pubmed: 30114188 pmcid: 6095488 doi: 10.1371/journal.pgen.1007545
Yamashita, T. et al. A vital role for glycosphingolipid synthesis during development and differentiation. Proc. Natl Acad. Sci. USA 96, 9142–9147 (1999).
pubmed: 10430909 doi: 10.1073/pnas.96.16.9142
Yamashita, T. et al. Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions. Proc. Natl Acad. Sci. USA 102, 2725–2730 (2005).
pubmed: 15710896 doi: 10.1073/pnas.0407785102
Yoshikawa, M. et al. Mice lacking ganglioside GM3 synthase exhibit complete hearing loss due to selective degeneration of the organ of Corti. Proc. Natl Acad. Sci. USA 106, 9483–9488 (2009).
pubmed: 19470479 doi: 10.1073/pnas.0903279106
Wang, E., Norred, W. P., Bacon, C. W., Riley, R. T. & Merrill, A. H. Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. J. Biol. Chem. 266, 14486–14490 (1991).
pubmed: 1860857
Horvath, A., Sütterlin, C., Manning‐Krieg, U., Movva, N. R. & Riezman, H. Ceramide synthesis enhances transport of GPI‐anchored proteins to the Golgi apparatus in yeast. EMBO J. 13, 3687–3695 (1994).
pubmed: 8070398 pmcid: 395279 doi: 10.1002/j.1460-2075.1994.tb06678.x
Dejgaard, S. Y., Murshid, A., Dee, K. M. & Presley, J. F. Confocal microscopy-based linescan methodologies for intra-Golgi localization of proteins. J. Histochem. Cytochem. 55, 709–719 (2007).
pubmed: 17341478 doi: 10.1369/jhc.6A7090.2007
Martina, J. A., Daniotti, J. L. & Maccioni, H. J. F. GM1 synthase depends on N-glycosylation for enzyme activity and trafficking to the Golgi complex. Neurochem. Res. 25, 725–731 (2000).
pubmed: 10905635 doi: 10.1023/A:1007527523734
Giraudo, C. G., Fritz, V. M. R. & Maccioni, H. J. F. GA2/GM2/GD2 synthase localizes to the trans-Golgi network of CHO-K1 cells. Biochem. J. 342, 633–640 (1999).
pubmed: 10477274 pmcid: 1220504 doi: 10.1042/bj3420633
Hampton, R. Y., Gardner, R. G. & Rine, J. Role of 26S proteasome and HRD genes in the degradation of 3-hydroxy-3-methylglutaryl-CoA reductase, an integral endoplasmic reticulum membrane protein. Mol. Biol. Cell 7, 2029–2044 (1996).
pubmed: 8970163 pmcid: 276048 doi: 10.1091/mbc.7.12.2029
Sun, S. et al. IRE1α is an endogenous substrate of endoplasmic-reticulum-associated degradation. Nat. Cell Biol. 17, 1546–1555 (2015).
pubmed: 26551274 pmcid: 4670240 doi: 10.1038/ncb3266
Burr, M. L. et al. HRD1 and UBE2J1 target misfolded MHC class I heavy chains for endoplasmic reticulum-associated degradation. Proc. Natl Acad. Sci. USA 108, 2034–2039 (2011).
pubmed: 21245296 doi: 10.1073/pnas.1016229108
Lilley, B. N. & Ploegh, H. L. Multiprotein complexes that link dislocation, ubiquitination, and extraction of misfolded proteins from the endoplasmic reticulum membrane. Proc. Natl Acad. Sci. USA 102, 14296–14301 (2005).
pubmed: 16186509 doi: 10.1073/pnas.0505014102
Oda, Y. et al. Derlin-2 and Derlin-3 are regulated by the mammalian unfolded protein response and are required for ER-associated degradation. J. Cell Biol. 172, 383–393 (2006).
pubmed: 16449189 pmcid: 2063648 doi: 10.1083/jcb.200507057
van der Goot, A. T., Pearce, M. M. P., Leto, D. E., Shaler, T. A. & Kopito, R. R. Redundant and antagonistic roles of XTP3B and OS9 in decoding glycan and non-glycan degrons in ER-associated degradation. Mol. Cell 70, 516–530.e6 (2018).
pubmed: 29706535 pmcid: 5935522 doi: 10.1016/j.molcel.2018.03.026
Ohishi, K., Inoue, N. & Kinoshita, T. PIG-S and PIG-T, essential for GPI anchor attachment to proteins, form a complex with GAA1 and GPI8. EMBO J. 20, 4088–4098 (2001).
pubmed: 11483512 pmcid: 149153 doi: 10.1093/emboj/20.15.4088
Oriol, R., Martinez-Duncker, I., Chantret, I., Mollicone, R. & Codogno, P. Common origin and evolution of glycosyltransferases Using Dol-P-monosaccharides as donor substrate. Mol. Biol. Evol. 19, 1–13 (2002).
doi: 10.1093/oxfordjournals.molbev.a004208
Cortes, L. K., Scarcelli, J. J. & Taron, C. H. Complementation of essential yeast GPI mannosyltransferase mutations suggests a novel specificity for certain Trypanosoma and Plasmodium pigB proteins. PLoS ONE 9, e87673 (2014).
pubmed: 24489949 pmcid: 3906172 doi: 10.1371/journal.pone.0087673
Young, W. W., Lutz, M. S., Mills, S. E. & Lechler-Osborn, S. Use of brefeldin A to define sites of glycosphingolipid synthesis: GA2/GM2/GD2 synthase is trans to the brefeldin A block. Proc. Natl Acad. Sci. USA 87, 6838–6842 (1990).
pubmed: 2118658 doi: 10.1073/pnas.87.17.6838 pmcid: 2118658
D’Angelo, G. et al. Vesicular and non-vesicular transport feed distinct glycosylation pathways in the Golgi. Nature 501, 116–120 (2013).
pubmed: 23913272 doi: 10.1038/nature12423 pmcid: 23913272
Giraudo, C. G., Daniotti, J. L. & Maccioni, H. J. F. Physical and functional association of glycolipid N-acetyl-galactosaminyl and galactosyl transferases in the Golgi apparatus. Proc. Natl Acad. Sci. USA 98, 1625–1630 (2001).
pubmed: 11172001 doi: 10.1073/pnas.98.4.1625 pmcid: 11172001
Halter, D. et al. Pre- and post-Golgi translocation of glucosylceramide in glycosphingolipid synthesis. J. Cell Biol. 179, 101–115 (2007).
pubmed: 17923531 pmcid: 2064740 doi: 10.1083/jcb.200704091
Young, W. W., Allende, M. L. & Jaskiewicz, E. Reevaluating the effect of Brefeldin A (BFA) on ganglioside synthesis: the location of GM2 synthase cannot be deduced from the inhibition of GM2 synthesis by BFA. Glycobiology 9, 689–695 (1999).
pubmed: 10362838 doi: 10.1093/glycob/9.7.689 pmcid: 10362838
Ng, B. G. & Freeze, H. H. Human genetic disorders involving glycosylphosphatidylinositol (GPI) anchors and glycosphingolipids (GSL). J. Inherit. Metab. Dis. 38, 171–178 (2014).
pubmed: 25164783 pmcid: 4373530 doi: 10.1007/s10545-014-9752-1
Ashida, H. et al. Mammalian PIG-X and yeast Pbn1p are the essential components of glycosylphosphatidylinositol-mannosyltransferase I. Mol. Biol. Cell 16, 1439–1448 (2005).
pubmed: 15635094 pmcid: 551505 doi: 10.1091/mbc.e04-09-0802
Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet. J. 17, 10 (2011).
doi: 10.14806/ej.17.1.200
Song, L., Florea, L. & Langmead, B. Lighter: fast and memory-efficient sequencing error correction without counting. Genome Biol. 15, 509 (2014).
pubmed: 25398208 pmcid: 4248469 doi: 10.1186/s13059-014-0509-9
Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078–2079 (2009).
pubmed: 19505943 pmcid: 19505943 doi: 10.1093/bioinformatics/btp352
Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science. 339, 819–823 (2013).
pubmed: 23287718 pmcid: 3795411 doi: 10.1126/science.1231143
Hirata, T. et al. Post-Golgi anterograde transport requires GARP-dependent endosome-to-TGN retrograde transport. Mol. Biol. Cell 26, 3071–3084 (2015).
pubmed: 26157166 pmcid: 4551320 doi: 10.1091/mbc.E14-11-1568
Haeussler, M. et al. Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR. Genome Biol. 17, 148 (2016).
pubmed: 27380939 pmcid: 4934014 doi: 10.1186/s13059-016-1012-2
Alam, S. et al. Altered (neo-) lacto series glycolipid biosynthesis impairs α2-6 sialylation on N-glycoproteins in ovarian cancer cells. Sci. Rep. 7, 45367 (2017).
pubmed: 28358117 pmcid: 5371825 doi: 10.1038/srep45367
Hirose, S. et al. Characterization of putative glycoinositol phospholipid anchor precursors in mammalian cells. Localization phosphoethanolamine. J. Biol. Chem. 267, 16968–16974 (1992).
pubmed: 1380957
Chen, C., Xia, R., Chen, H. & He, Y. TBtools, a Toolkit for Biologists integrating various biological data handling tools with a user-friendly interface. Preprint at https://doi.org/10.1101/289660 (2018).
Perez-Riverol, Y. et al. The PRIDE database and related tools and resources in 2019: Improving support for quantification data. Nucleic Acids Res. 47, D442–D450 (2019).
doi: 10.1093/nar/gky1106
Varki, A. et al. Symbol nomenclature for graphical representations of glycans. Glycobiology 25, 1323–1324 (2015).
pubmed: 26543186 pmcid: 4643639 doi: 10.1093/glycob/cwv091

Auteurs

Yicheng Wang (Y)

Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, 565-0871, Japan.
WPI Immunology Frontier Research Center, Osaka University, Suita, Osaka, 565-0871, Japan.

Yusuke Maeda (Y)

Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, 565-0871, Japan.

Yi-Shi Liu (YS)

Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, Jiangsu, 214122, China.

Yoko Takada (Y)

WPI Immunology Frontier Research Center, Osaka University, Suita, Osaka, 565-0871, Japan.

Akinori Ninomiya (A)

Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, 565-0871, Japan.

Tetsuya Hirata (T)

Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, 565-0871, Japan.
WPI Immunology Frontier Research Center, Osaka University, Suita, Osaka, 565-0871, Japan.
Center for Highly Advanced Integration of Nano and Life Sciences (G-CHAIN), Gifu University, 1-1 Yanagido, Gifu-City, Gifu 501-1193, Japan.

Morihisa Fujita (M)

Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, Jiangsu, 214122, China.

Yoshiko Murakami (Y)

Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, 565-0871, Japan.
WPI Immunology Frontier Research Center, Osaka University, Suita, Osaka, 565-0871, Japan.

Taroh Kinoshita (T)

Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, 565-0871, Japan. tkinoshi@biken.osaka-u.ac.jp.
WPI Immunology Frontier Research Center, Osaka University, Suita, Osaka, 565-0871, Japan. tkinoshi@biken.osaka-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH